Investors are overly optimistic about the prospects for this company.

Before the election, Trump toyed with the idea of a 60% tariff hike on Chinese imports and a 10% universal tariff. We still ...

Please note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...

Morningstar Investment Management's Chief Investment Officer for Asia Pacific weighs in on the weak Aussie dollar and what ...

The Chart of the Week looks at Morningstar's stock valuations for the Australian market and how it compares to the past.

The final quarter of 2024 presented a mixed bag for the New Zealand economy. While some indicators pointed towards a ...

Managed funds have been around for a long while. Some of Australia’s oldest managed funds were launched over 65 years ago. It ...

Below are a few emotional biases to be aware of before making an investing decision. Have you ever experienced the sunk cost fallacy? When you’ve invested too much time, effort or money into a pursuit ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...

A new year of investing insights.

Sharesight is a portfolio tracker that is integrated into Morningstar Investor. Their data shows the top 20 trades by ...

Getting regular, growing income from stocks is tougher with the dividend yield on the ASX nearing 25-year lows. Here are some ...